Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMolten Ventures Regulatory News (MVCT)

Share Price Information for Molten Ventures (MVCT)

Share Price is delayed by 15 minutes
Get Live Data
37.80    0.00 (0.00%)
Bid:
36.80
Ask:
38.80
Spread: 2.00 (5.435%)
Market Cap: £119.60m
MVCT Live PriceLast checked at - London Stock Exchange

Intraday Molten Ventures Share Chart

Net Asset Value and Dividend Outlook

14 Feb 2023 10:48

Net Asset Value and Dividend Outlook

Molten Ventures VCT plcLEI: 2138003I9Q1QPDSQ9Z97Net Asset Value and Dividend Outlook14 February 2023

Molten Ventures VCT plc (“the Company”) announces that its estimated unaudited Net Asset Value (“NAV”) of the Company at 31 December 2022 was 51.2p per share.

The Board has reviewed updated projections incorporating the updated NAV and considered the potential impact on dividends. The Board has a target to pay a tax-free dividend of approximately 5% of the Company’s prevailing NAV per annum, subject to liquidity, VCT regulations and Listing Rules. The Board notes that, in order to ensure continued compliance with the VCT regulations, subject to the level of profitable realisations that may be achieved from the portfolio, and movements of AIM-quoted holdings, the dividend level may be lower than the target in the next financial year. The Board will continue to review the dividend target on an ongoing basis and maintains its intention to pay dividends. It should be noted that any amounts that are not paid out as dividends will remain as funds within the net assets of the Company.

12
Date   Source Headline
30th Jun 20263:18 pmRNSOffer for Subscription update on close date
18th Jun 20267:00 amRNSFinal Results
1st May 202610:08 amRNSTotal Voting Rights
24th Apr 20267:00 amRNSIssue of Equity
17th Apr 202612:16 pmRNSIssue of Equity
7th Apr 20264:16 pmRNSDirector/PDMR Shareholding
7th Apr 20261:22 pmRNSIssue of Equity
19th Mar 202612:05 pmRNSDividend Declaration
24th Feb 20267:00 amRNSOffer for Subscription - Update
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
15th Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSHalf-year Financial Report
7th Oct 202511:31 amRNSPublication of a Prospectus
1st Oct 202510:31 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSIssue of Equity under DRIS
17th Sep 20252:45 pmRNSResult of AGM
19th Jun 20257:00 amRNSFinal Results
1st May 20259:25 amRNSTotal Voting Rights
30th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSIssue of Equity
16th Apr 20254:40 pmRNSDirector/PDMR Shareholding
16th Apr 20254:39 pmRNSDirector/PDMR Shareholding
16th Apr 202512:37 pmRNSIssue of Equity
15th Apr 20257:00 amRNSDirector/PDMR Shareholding
4th Apr 20257:00 amRNSIssue of Equity
1st Apr 20252:33 pmRNSDirectorate Change
25th Mar 20258:48 amRNSOffer for Subscription – Update
24th Mar 20252:42 pmRNSDirector Declaration
20th Mar 20254:48 pmRNSDividend Declaration
13th Dec 202412:08 pmRNSHalf-year Report updated
12th Dec 20247:00 amRNSHalf-year Report
11th Oct 202412:20 pmRNSOffer for Subscription
1st Oct 20249:43 amRNSTotal Voting Rights
26th Sep 20241:03 pmRNSIssue of Equity
9th Sep 202411:49 amRNSIntention to launch a fundraising offer
4th Sep 20243:33 pmRNSResult of AGM
2nd Sep 202410:05 amRNSTotal Voting Rights
16th Aug 20248:15 amRNSIssue of Equity
1st Aug 202411:12 amRNSOffer for Subscription - Update
30th Jul 202410:16 amRNSAnnual Financial Report - NSM upload
29th Jul 20247:00 amRNSFinal Results
18th Jun 20242:44 pmRNSOffer Update
1st May 20244:11 pmRNSPortfolio Update
1st May 20249:36 amRNSTotal Voting Rights
24th Apr 20243:31 pmRNSIssue of Equity
15th Apr 20246:04 pmRNSTransaction in Own Shares
23rd Jan 202412:34 pmGNWDirectorate change
29th Dec 202310:03 amGNWForm 8.3 - [MOLTEN VENTURES PLC - 28 12 2023] - (CGAML)
14th Dec 202312:35 pmGNWHalf-year report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.